Literature DB >> 22901386

D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation.

Tao Zhang1, Li-Hui Lu, Hao Liu, Jun-Wei Wang, Rui-Xue Wang, Yun-Xiao Zhang, Jing-Chao Tao.   

Abstract

A series of polyhydric, amino alcohol and tricyclic derivatives were facilely synthesized by D-ring modification of isosteviol. These compounds were screened for their cytotoxic activities against four human tumor cell lines in vitro. Among them, the 15-α-aminomethyl-16-β-hydroxyl isosteviol 23 exhibits significant cytotoxicity superior to the positive control (cisplatin) against EC9706, PC-3 and HCT-116 cell lines.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901386     DOI: 10.1016/j.bmcl.2012.07.083

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.

Authors:  Ravil N Khaybullin; Xiao Liang; Katherine Cisneros; Xin Qi
Journal:  Future Med Chem       Date:  2015-12-11       Impact factor: 3.808

2.  Design and synthesis of isosteviol triazole conjugates for cancer therapy.

Authors:  Ravil N Khaybullin; Mei Zhang; Junjie Fu; Xiao Liang; Tammy Li; Alan R Katritzky; Paul Okunieff; Xin Qi
Journal:  Molecules       Date:  2014-11-14       Impact factor: 4.411

3.  Synthesis and Biological Application of Isosteviol-Based 1,3-Aminoalcohols.

Authors:  Dániel Ozsvár; Viktória Nagy; István Zupkó; Zsolt Szakonyi
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

4.  Development and validation of an LC-MS/MS method for quantification of NC-8 in rat plasma and its application to pharmacokinetic studies.

Authors:  Baxter Hepburn Kachingwe; Yow-Shieng Uang; Tsurng-Juhn Huang; Li-Hsuan Wang; Shwu-Jiuan Lin
Journal:  J Food Drug Anal       Date:  2017-11-11       Impact factor: 6.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.